Search

Author/Creator Cohan, D.

2. P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS. (23rd June 2022)

Authors:
Zinzani, P. L.; Zain, J.; Mead, M.; Casulo, C.; Jacobsen, E. D.; Gritti, G.; Pinter-Brown, L.; Isutzu, K.; Cohan, D.; Daugherty, M.; Brammer, J. E.; Mehta-Shah, N.; Pro, B.; Horwitz, S. M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1058
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P1123: TEMPO: A PHASE 2, RANDOMIZED, OPEN-LABEL, 2-ARM STUDY COMPARING TWO INTERMITTENT DOSING SCHEDULES OF DUVELISIB IN SUBJECTS WITH INDOLENT NON-HODGKIN LYMPHOMA (INHL). (23rd June 2022)

Authors:
Vorobyev, V.; Yoon, D. H.; Kaźmierczak, M.; Grosicki, S.; Tarella, C.; Genua, A.; Kim, J. S.; Cohan, D.; Daugherty, M.; Flinn, I. W.; Zinzani, P. L.; Gordon, L. I.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1013
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗